Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.

Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
05 Dec 2019
Historique:
entrez: 6 12 2019
pubmed: 6 12 2019
medline: 6 12 2019
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41419-019-2113-0 PMID: 31804458 PMC: PMC6895075
pubmed: 31804458
doi: 10.1038/s41419-019-2113-0
pii: 10.1038/s41419-019-2113-0
pmc: PMC6895075
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

933

Commentaires et corrections

Type : ErratumFor

Auteurs

Rui Guo (R)

Center for Cardiovascular Research and Alternative Medicine, School of Pharmacy College of Health Sciences, University of Wyoming, Laramie, WY, 82071, USA.

Yinan Hua (Y)

Center for Cardiovascular Research and Alternative Medicine, School of Pharmacy College of Health Sciences, University of Wyoming, Laramie, WY, 82071, USA.

Jun Ren (J)

Center for Cardiovascular Research and Alternative Medicine, School of Pharmacy College of Health Sciences, University of Wyoming, Laramie, WY, 82071, USA.
ORCID: 0000-0002-0275-0783

Karin E Bornfeldt (KE)

UW Medicine Diabetes Institute, Departments of Medicine, Division of Metabolism, Endocrinology and Nutrition, and Pathology, School of Medicine, University of Washington, Seattle, WA, 98109, USA.

Sreejayan Nair (S)

Center for Cardiovascular Research and Alternative Medicine, School of Pharmacy College of Health Sciences, University of Wyoming, Laramie, WY, 82071, USA. sreejay@uwyo.edu.
ORCID: 0000-0002-1339-8260

Classifications MeSH